XWPharma
Latest round
- Series C
Last raised
- Sep 2020
Total raised
- $58M
Investors
- 10
About XWPharma
Established in 2014 and based in Wuhan, China, XWPharma Ltd. operates as a new drug development company dedicated to design and develop new drugs for central nervous system disorders. The founder and CSO of the company, Jianing Xiang graduated from California Institute of Technology and has worked in SmithKline Beecham. The CMO of the company, Daniel Canafax graduated from Washington State University and was a professor of pharmacy, surgery, and otolaryngology at the University of Minnesota. The company mainly develops biopharmaceuticals for neurological diseases. It has three pipelines, which are Valiloxybate, XW10508, and other programs. The Valiloxybate can be used for Narcolepsy and Non-motor Symptoms of Parkinson’s disease. The XW10508 can be applied to major depressive disorder (MDD) and chronic pain. The company generates revenue by providing biopharmaceuticals for neurological diseases.
Who invested in XWPharma
10 investors across 3 rounds
See all investors in XWPharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about XWPharma
Who invested in XWPharma?
XWPharma has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has XWPharma raised?
XWPharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did XWPharma last raise money?
XWPharma's most recent round on record is a Series C, in Sep 2020.
What does XWPharma do?
Established in 2014 and based in Wuhan, China, XWPharma Ltd.
Where is XWPharma headquartered?
XWPharma is headquartered in Wuhan, China.
Which VCs invest in companies like XWPharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at XWPharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like XWPharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.